Europaischer Markt für Arzneimittelverabreichungssysteme bis 2027 – Regionale Analyse und Prognosen nach Verabreichungsweg (transmukosale, orale, injizierbare, topische, implantierbare und okulare); Vertriebskanal (Krankenhausapotheken, Einzelhandelsapotheken und Online-Apotheken); und Anwendung (häusliche Pflegeeinrichtungen, Krankenhäuser und Kliniken und andere) und Geographie
Der europäische Markt für Arzneimittelverabreichungssysteme wird im Jahr 2027 voraussichtlich 610.320,4 Mio. US-Dollar erreichen, verglichen mit 343.533,9 Mio. 2027.
Faktoren wie steigende Investitionen von Pharmaunternehmen und Medizin Es wird erwartet, dass die Förderung von Forschung und Entwicklung durch Gerätehersteller und die Zunahme chronischer Krankheiten in Europa das Wachstum des europäischen Marktes für Arzneimittelverabreichungssysteme fördern werden. Andererseits dürften behördliche Rückrufe für Arzneimittelverabreichungssysteme durch europäische Hersteller in gewissem Maße negative Auswirkungen auf das Marktwachstum haben.
< span>Produkte mit innovativer Technologie mit wirksameren Vorteilen sind eine wichtige Voraussetzung bei der Behandlung verschiedener chronischer Krankheiten. Der Fortschritt und die Entwicklung in der Behandlung nehmen in den letzten Jahren zu. Da die Prävalenz chronischer Krankheiten im europäischen Raum zunimmt, steigt auch die Nachfrage nach mehr Produkten mit Weiterentwicklungen. Daher haben Forscher im Laufe der Jahre Forschungsaktivitäten durchgeführt, die zu Produktinnovationen geführt haben.
Zum Beispiel im Juli 2018 Roche erhielt die CE-Kennzeichnung für sein innovatives Mikropumpensystem Accu-Chek Solo. Bei dem System handelt es sich um ein kleines, schlauchloses Insulinabgabegerät, das seinen Benutzern die Möglichkeit bietet, den Bolus direkt aus der Pumpe zu verabreichen. Das System ist ein voll funktionsfähiges Handgerät, das die Funktion zum Abnehmen und Wiederanbringen der Pumpe bietet, ohne dass Insulin verschwendet wird. Die Accu-Chek Solo Mikropumpe integriert und die digitalen Gesundheitslösungen von Roche tragen in Kombination dazu bei, ihren Benutzern ein effektiveres und personalisierteres Diabetesmanagement zu bieten. Die Innovationen bei den Arzneimittelverabreichungssystemen dürften daher in den kommenden Jahren ein vorherrschender Trend auf dem globalen Markt für Arzneimittelverabreichungssysteme sein.
< span>Umsatz und Prognosen für den Markt für Arzneimittelverabreichungssysteme in Deutschland bis 2027 (Mio. US-Dollar)
Strategic insights for Europe Drug Delivery Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
Europe Drug Delivery Systems Report Scope
Report Attribute
Details
Market size in 2018
US$ 343,533.9 Million
Market Size by 2027
US$ 610,320.4 Million
Global CAGR (2019 - 2027)
6.7%
Historical Data
2016-2017
Forecast period
2019-2027
Segments Covered
By Verabreichungsweg
transmukosal
oral
injizierbar
topisch
implantierbar
okular
By Vertriebskanäle
Krankenhausapotheken
Einzelhandelsapotheken
Online-Apotheken
By Anwendung
häusliche Pflegeeinrichtungen
Krankenhäuser und Kliniken
Regions and Countries Covered
Europa
Großbritannien
Deutschland
Frankreich
Russland
Italien
Rest von Europa
Market leaders and key company profiles
BD
Novo Nordisk A/S
3M
Boston Scientific Corporation
Bausch Health Companies Inc.
Baxter International, Inc.
Boehringer Ingelheim
Novartis AG
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Get more information on this report
Europe Drug Delivery Systems Regional Insights
The regional scope of Europe Drug Delivery Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Europe Drug Delivery Systems Market
The List of Companies - Europe Drug Delivery Systems Market
BD
Novo Nordisk A/S
3M
Boston Scientific Corporation
Bausch Health Companies Inc.
Baxter International, Inc.
Boehringer Ingelheim
Novartis AG
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Frequently Asked Questions
How big is the Europe Drug Delivery Systems Market?
The Europe Drug Delivery Systems Market is valued at US$ 343,533.9 Million in 2018, it is projected to reach US$ 610,320.4 Million by 2027.
What is the CAGR for Europe Drug Delivery Systems Market by (2019 - 2027)?
As per our report Europe Drug Delivery Systems Market, the market size is valued at US$ 343,533.9 Million in 2018, projecting it to reach US$ 610,320.4 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.
What segments are covered in this report?
The Europe Drug Delivery Systems Market report typically cover these key segments-
Anwendung (häusliche Pflegeeinrichtungen, Krankenhäuser und Kliniken)
What is the historic period, base year, and forecast period taken for Europe Drug Delivery Systems Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Drug Delivery Systems Market report:
Historic Period : 2016-2017
Base Year : 2018
Forecast Period : 2019-2027
Who are the major players in Europe Drug Delivery Systems Market?
The Europe Drug Delivery Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
BD
Novo Nordisk A/S
3M
Boston Scientific Corporation
Bausch Health Companies Inc.
Baxter International, Inc.
Boehringer Ingelheim
Novartis AG
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Who should buy this report?
The Europe Drug Delivery Systems Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Europe Drug Delivery Systems Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Europe Drug Delivery Systems Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines